Not All Generics Are Created Equal: Study Exposes a 54% Higher Risk in Indian-Made Drugs
A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...
Food Allergy Cure? This FDA-Approved Drug Helps Kids Eat Peanuts, Milk, And More!
A new clinical trial reveals that the asthma drug omalizumab (Xolair) helps food-allergic children eat trigger foods safely.
Contract Pharma2 天
ENCell’s EN001 Granted Orphan Drug Designation by FDA
ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...
ENCell’s EN001 Receives Orphan Drug Designation from the U.S. FDA for Charcot-Marie-Tooth ...
EN001, ENCell’s therapy under development for the treatment of Charcot-Marie-Tooth (CMT) disease, has been granted Orphan ...
Zacks Investment Research on MSN4 天
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults
Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or ...
Bread Recall Update as FDA Issues Highest Risk Warning
The Food and Drug Administration (FDA) has classified a batch of bread rolls produced by Jesse's Bakery, Inc. in Honolulu, Hawaii, at its highest risk level, Class I, after the company recalled the ...
HealthDay on MSN5 天
Injectable Drug Resolves Dangerous Food Allergies In One-Third Of Kids
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Injectable asthma drug resolves dangerous food allergies in one-third of children
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
Roche's Xolair outperformed oral immunotherapy in a Phase 3 trial for food allergies, showing better tolerance and fewer ...
NJBIZ3 天
FDA alerts NJ pharma over ‘misleading’ cancer drug claims at conference
According to the agency, the 15-year-old company only presented efficacy claims for its branded medication and did not include any warnings or precautions for the tablets at a tradeshow.
The Manila Times5 天
Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT ...
STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) are approved by FDA for all indications of reference products ...
GlobalData on MSN1 天
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US FDA has approved scPharmaceuticals’ sNDA for Furoscix, expanding its indication to include oedema treatment in ...